Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study

NCT01584466 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone

Sponsor

University of Maryland, Baltimore